Búsqueda | Portal de Búsqueda de la BVS España

1.

Chi3l1: New kid on the T cell blockade.

He, Mi; Kok, Marleen.

Immunity; 56(12): 2672-2674, 2023 Dec 12.

Artículo en Inglés | MEDLINE | ID: mdl-38091946

2.

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.

Wang, Yuwei; Dackus, Gwen M H E; Rosenberg, Efraim H; Cornelissen, Sten; de Boo, Leonora W; Broeks, Annegien; Brugman, Wim; Chan, Terry W S; van Diest, Paul J; Hauptmann, Michael; Ter Hoeve, Natalie D; Isaeva, Olga I; de Jong, Vincent M T; Józwiak, Katarzyna; Kluin, Roelof J C; Kok, Marleen; Koop, Esther; Nederlof, Petra M; Opdam, Mark; Schouten, Philip C; Siesling, Sabine; van Steenis, Charlaine; Voogd, Adri C; Vreuls, Willem; Salgado, Roberto F; Linn, Sabine C; Schmidt, Marjanka K.

BMC Med; 22(1): 9, 2024 01 09.

Artículo en Inglés | MEDLINE | ID: mdl-38191387

3.

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.

Leon-Ferre, Roberto A; Jonas, Sarah Flora; Salgado, Roberto; Loi, Sherene; de Jong, Vincent; Carter, Jodi M; Nielsen, Torsten O; Leung, Samuel; Riaz, Nazia; Chia, Stephen; Jules-Clément, Gérôme; Curigliano, Giuseppe; Criscitiello, Carmen; Cockenpot, Vincent; Lambertini, Matteo; Suman, Vera J; Linderholm, Barbro; Martens, John W M; van Deurzen, Carolien H M; Timmermans, A Mieke; Shimoi, Tatsunori; Yazaki, Shu; Yoshida, Masayuki; Kim, Sung-Bae; Lee, Hee Jin; Dieci, Maria Vittoria; Bataillon, Guillaume; Vincent-Salomon, Anne; André, Fabrice; Kok, Marleen; Linn, Sabine C; Goetz, Matthew P; Michiels, Stefan.

JAMA; 331(13): 1135-1144, 2024 04 02.

Artículo en Inglés | MEDLINE | ID: mdl-38563834

4.

B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer.

Steenbruggen, Tessa G; Wolf, Denise M; Campbell, Michael J; Sanders, Joyce; Cornelissen, Sten; Thijssen, Bram; Salgado, Roberto A; Yau, Christina; O-Grady, Nick; Basu, Amrita; Bhaskaran, Rajith; Mittempergher, Lorenza; Hirst, Gillian L; Coppe, Jean-Philippe; Kok, Marleen; Sonke, Gabe S; van 't Veer, Laura J; Horlings, Hugo M.

Breast Cancer Res; 25(1): 117, 2023 10 04.

Artículo en Inglés | MEDLINE | ID: mdl-37794508

5.

Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions.

Schutte, Tim; Zeverijn, Laurien J; Geurts, Birgit S; de Wit, Gijsbrecht F; Kok, Marleen; Opdam, Frans L.

Oncologist; 28(7): e493-e497, 2023 07 05.

Artículo en Inglés | MEDLINE | ID: mdl-37086483

6.

Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches.

Geurts, Veerle; Kok, Marleen.

Curr Treat Options Oncol; 24(6): 628-643, 2023 06.

Artículo en Inglés | MEDLINE | ID: mdl-37079257

7.

A qualitative study on the healthcare experiences of adolescents and young adults (AYA) with an uncertain or poor cancer prognosis.

Burgers, Vivian W G; Reuvers, Milou J P; Taphoorn, Martin J B; Kok, Marleen; de Langen, Adrianus J; van den Bent, Martin J; Frissen, Simone A M M; Harthoorn, Niels C G L; Dickhout, Annemiek; Husson, Olga; van der Graaf, Winette T A.

Support Care Cancer; 31(12): 721, 2023 Nov 27.

Artículo en Inglés | MEDLINE | ID: mdl-38008874

8.

Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review.

van den Ende, Nadine S; Nguyen, Anh H; Jager, Agnes; Kok, Marleen; Debets, Reno; van Deurzen, Carolien H M.

Int J Mol Sci; 24(3)2023 Feb 03.

Artículo en Inglés | MEDLINE | ID: mdl-36769287

9.

Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients.

de Boo, Leonora W; Józwiak, Katarzyna; Joensuu, Heikki; Lindman, Henrik; Lauttia, Susanna; Opdam, Mark; van Steenis, Charlaine; Brugman, Wim; Kluin, Roelof J C; Schouten, Philip C; Kok, Marleen; Nederlof, Petra M; Hauptmann, Michael; Linn, Sabine C.

Br J Cancer; 126(10): 1401-1409, 2022 06.

Artículo en Inglés | MEDLINE | ID: mdl-35124703

10.

The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.

Gonzalez-Ericsson, Paula I; Stovgaard, Elisabeth S; Sua, Luz F; Reisenbichler, Emily; Kos, Zuzana; Carter, Jodi M; Michiels, Stefan; Le Quesne, John; Nielsen, Torsten O; Laenkholm, Anne-Vibeke; Fox, Stephen B; Adam, Julien; Bartlett, John Ms; Rimm, David L; Quinn, Cecily; Peeters, Dieter; Dieci, Maria V; Vincent-Salomon, Anne; Cree, Ian; Hida, Akira I; Balko, Justin M; Haynes, Harry R; Frahm, Isabel; Acosta-Haab, Gabriela; Balancin, Marcelo; Bellolio, Enrique; Yang, Wentao; Kirtani, Pawan; Sugie, Tomoharu; Ehinger, Anna; Castaneda, Carlos A; Kok, Marleen; McArthur, Heather; Siziopikou, Kalliopi; Badve, Sunil; Fineberg, Susan; Gown, Allen; Viale, Giuseppe; Schnitt, Stuart J; Pruneri, Giancarlo; Penault-Llorca, Frederique; Hewitt, Stephen; Thompson, E Aubrey; Allison, Kimberly H; Symmans, William F; Bellizzi, Andrew M; Brogi, Edi; Moore, David A; Larsimont, Denis; Dillon, Deborah A.

J Pathol; 250(5): 667-684, 2020 04.

Artículo en Inglés | MEDLINE | ID: mdl-32129476

11.

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes.

Sobral-Leite, Marcelo; Salomon, Izhar; Opdam, Mark; Kruger, Dinja T; Beelen, Karin J; van der Noort, Vincent; van Vlierberghe, Ronald L P; Blok, Erik J; Giardiello, Daniele; Sanders, Joyce; Van de Vijver, Koen; Horlings, Hugo M; Kuppen, Peter J K; Linn, Sabine C; Schmidt, Marjanka K; Kok, Marleen.

Breast Cancer Res; 21(1): 90, 2019 08 07.

Artículo en Inglés | MEDLINE | ID: mdl-31391067

12.

Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.

Nederlof, Iris; De Bortoli, Davide; Bareche, Yacine; Nguyen, Bastien; de Maaker, Michiel; Hooijer, Gerrit K J; Buisseret, Laurence; Kok, Marleen; Smid, Marcel; Van den Eynden, Gert G G M; Brinkman, Arie B; Hudecek, Jan; Koster, Jan; Sotiriou, Christos; Larsimont, Denis; Martens, John W M; van de Vijver, Marc J; Horlings, Hugo M; Salgado, Roberto; Biganzoli, Elia; Desmedt, Christine.

Breast Cancer Res; 21(1): 151, 2019 12 26.

Artículo en Inglés | MEDLINE | ID: mdl-31878981

13.

Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?

Agahozo, Marie Colombe; Hammerl, Dora; Debets, Reno; Kok, Marleen; van Deurzen, Carolien H M.

Mod Pathol; 31(7): 1012-1025, 2018 07.

Artículo en Inglés | MEDLINE | ID: mdl-29463884

14.

Targeting the programmed cell death-1 pathway in breast and ovarian cancer.

Emens, Leisha A; Kok, Marleen; Ojalvo, Laureen S.

Curr Opin Obstet Gynecol; 28(2): 142-7, 2016 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-26881392

15.

Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer.

Zwart, Wilbert; Theodorou, Vasiliki; Kok, Marleen; Canisius, Sander; Linn, Sabine; Carroll, Jason S.

EMBO J; 30(23): 4764-76, 2011 Oct 14.

Artículo en Inglés | MEDLINE | ID: mdl-22002538

16.

Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13.

Bentin Toaldo, Cristiane; Alexi, Xanthippi; Beelen, Karin; Kok, Marleen; Hauptmann, Michael; Jansen, Maurice; Berns, Els; Neefjes, Jacques; Linn, Sabine; Michalides, Rob; Zwart, Wilbert.

BMC Cancer; 15: 588, 2015 Aug 14.

Artículo en Inglés | MEDLINE | ID: mdl-26272591

17.

Radiological, pathological and surgical outcomes after neoadjuvant endocrine treatment in patients with ER-positive/HER2-negative breast cancer with a clinical high risk and a low-risk 70-gene signature.

van Olmen, Josefien P; Jacobs, Chaja F; Bartels, Sanne A L; Loo, Claudette E; Sanders, Joyce; Vrancken Peeters, Marie-Jeanne T F D; Drukker, Caroline A; van Duijnhoven, Frederieke H; Kok, Marleen.

Breast; 75: 103726, 2024 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-38599047

18.

Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol.

Geurts, Birgit S; Zeverijn, Laurien J; Leek, Lindsay V M; van Berge Henegouwen, Jade M; Hoes, Louisa R; van der Wijngaart, Hanneke; van der Noort, Vincent; van de Haar, Joris; van Ommen-Nijhof, Annemiek; Kok, Marleen; Roepman, Paul; Jansen, Anne M L; de Leng, Wendy W J; de Jonge, Maja J A; Hoeben, Ann; van Herpen, Carla M L; Westgeest, Hans M; Wessels, Lodewyk F A; Verheul, Henk M W; Gelderblom, Hans; Voest, Emile E.

Clin Cancer Res; 2024 Apr 17.

Artículo en Inglés | MEDLINE | ID: mdl-38630551

19.

Immunological profile of Fanconi anemia: a multicentric retrospective analysis of 61 patients.

Korthof, Elisabeth T; Svahn, Johanna; Peffault de Latour, Regis; Terranova, Paola; Moins-Teisserenc, Helene; Socié, Gérard; Soulier, Jean; Kok, Marleen; Bredius, Robbert G M; van Tol, Maarten; Jol-van der Zijde, Els C M; Pistorio, Angela; Corsolini, Fabio; Parodi, Alessia; Battaglia, Florinda; Pistoia, Vito; Dufour, Carlo; Cappelli, Enrico.

Am J Hematol; 88(6): 472-6, 2013 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-23483621

20.

Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative Breast Cancer.

Nederlof, Iris; Voorwerk, Leonie; Kok, Marleen.

Clin Cancer Res; 29(13): 2362-2370, 2023 07 05.

Artículo en Inglés | MEDLINE | ID: mdl-36622327

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: